期刊文献+

伏立康唑治疗急性白血病患者肺部真菌感染一例并文献复习 被引量:1

下载PDF
导出
摘要 目的:通过总结一例急性白血病患者肺部真菌感染的诊治,结合文献资料,分析伏立康唑治疗恶性血液病患者被侵袭性真菌感染的疗效和安全性。方法:一例白血病患者在化疗间歇骨髓抑制期合并严重肺部念珠菌与绿脓杆菌混合感染,并对氟康唑产生耐药性,应用伏立康唑及联合抗细菌治疗,同时观察药物的不良反应。结果:感染得到及时有效的控制,挽救了患者的生命,且无明显不良反应发生。结论:伏立康唑在治疗恶性血液病患者侵袭性真菌感染中具有广谱抗真菌功效,同时它所引发的不良事件较少且多能耐受。
作者 冀林华 罗伟
出处 《青海医药杂志》 2011年第2期17-18,共2页 Qinghai Medical Journal
  • 相关文献

参考文献8

  • 1Pagano L, Caira M, Valentini CG, et al. Current therapeutic approaches to fungal infections in immunocompromised hematological patients. Blood Rev ,2010 ,24 (2) :51 -61.
  • 2Fera MT, La Camera E, De Sarro A. New triazoles and echinocandins : mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther,2009,7(8) :981-998.
  • 3Kaya Z, Gursel T, Kocak U, et al. Invasive,e fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis. Pediatr Blood Caneer,2009,52(4) :470 - 475.
  • 4Denning DW, Riband P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clinical Infectious Diseases,2002,34:563.
  • 5Amigues I, Cohen N, Chung D, et al. Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant,2010,16(1) :46-52.
  • 6Ghannoum MA, Knhu DM. Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res ,2002,31 (5) : 242 - 256.
  • 7A1 - Badriyeh D, Liew D, Stewart K, et al. Cost - effective - ness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia. Antimicrob Chemother,20(O,63( 1 ) : 197 -208.
  • 8Rotstein C, Cragin L, Laverdière M, et al. Economic evaluation of voriconazole for the treatment of candidemia in Canadian adults. Can J Infect Dis Med Microbiol,2008,19(3) : 219 - 226.

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部